ALFA Finder
20:27 IST
BSE
Other Announcement
Dr. Lalchandani Labs Other Announcement
Dr Lalchandani Labs Ltd. received an extension from the Registrar of Companies to hold its AGM for FY 2025-26 by December 31, 2026.
Dr. Lalchandani Labs Ltd
- Share price
- ₹6.57
- Market cap
- ₹5.69 Cr
- Revenue (annual)
- ₹4.19 Cr
- Net profit (annual)
- ₹0.06 Cr
- P/E (TTM)
- 89.5×Sector 54.5×
- Promoter holding
- 32.90%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
21:28 IST
BSE
Financial Results
Dr. Lalchandani Labs H2 FY26 Results: Net Loss of ₹0.1 Cr
Dr. Lalchandani Labs Ltd reported revenue from operations of ₹2.1 Cr (-8.7% YoY) and a net loss of ₹0.1 Cr for H2 FY26.
- Key figure
- Net loss ₹0.1 Cr
19:30 IST
BSE
Board Meeting Date
Dr. Lalchandani Labs Board Meeting Date
Dr Lalchandani Labs Limited postponed its May 30 board meeting to June 03, 2026. The delay allows for internal review of financial data before results approval.
18:13 IST
BSE
Capacity Expansion
Dr. Lalchandani Labs Capacity Expansion: ₹1 Cr Investment
Dr Lalchandani Labs opened a new strategic centre in Dwarka, Delhi. The facility targets a ₹1 Crore annual revenue contribution from local government employee residents.
- Value
- ₹1.00 Cr
18:01 IST
BSE
Board Meeting Date
Dr. Lalchandani Labs Board Meeting Date
Dr Lalchandani Labs scheduled a board meeting on May 30, 2026, to approve annual audited financial results. The trading window remains closed until June 1.